Company News
Parabilis Medicines IPO Opens 67% Above Price
Parabilis Medicines shares debuted at $33.35, a 67% premium to its $20 IPO price.
The stock later settled at $29.50, still 47.5% above the IPO price.
The upsized offering of 33.5 million shares target
